OksanaShlobinMD
Pulmonology • Falls Church, VACritical Care Medicine, Pleural Disease
Medical Director, Pulmonary Hypertension Program
Dr. Shlobin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3300 Gallows Rd
# Physicia
Falls Church, VA 22042Phone+1 703-776-1110Fax+1 703-776-1110
Education & Training
Johns Hopkins UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 2002 - 2005
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1999 - 2002
Georgetown University School of MedicineClass of 1999
Certifications & Licensure
VA State Medical License 2004 - 2026
MD State Medical License 2003 - 2005- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program Start of enrollment: 2011 Jun 01
- Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Adults With Idiopathic Pulmonary Fibrosis (IPF) Start of enrollment: 2013 Jan 31
- Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument Start of enrollment: 2013 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- Parenteral prostacyclin utilization in patients with pulmonary arterial hypertension in the intermediate-risk strata: a retrospective chart review and cross-sectional ...Anjali Vaidya, Margaret R Sketch, Meredith Broderick, Oksana A Shlobin
BMC Pulmonary Medicine. 2024-11-20 - 1 citationsPreacinar Arterial Dilation Mediates Outcomes of Quantitative Interstitial Abnormalities in the COPDGene Study.Eileen M Harder, Pietro Nardelli, Carrie L Pistenmaa, Samuel Y Ash, Aparna Balasubramanian
American Journal of Respiratory and Critical Care Medicine. 2024-11-01 - 1 citationsSafety and efficacy of rodatristat ethyl for the treatment of pulmonary arterial hypertension (ELEVATE-2): a dose-ranging, randomised, multicentre, phase 2b trial.Olivier Sitbon, Andris Skride, Jeremy Feldman, Sandeep Sahay, Oksana A Shlobin
The Lancet. Respiratory Medicine. 2024-11-01
Press Mentions
Identifying and Navigating Challenging Clinical Scenarios in Pulmonary Arterial HypertensionAugust 25th, 2022
New Pulmonary Hypertension Association Accreditation Program and Registry Giving New Understanding to Specialists Caring for People Living with Pulmonary HypertensionFebruary 3rd, 2017
Other Languages
- Russian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
